Is $1B in recent deals a reason for optimism in Mass. biotech?
Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a bitterly cold stretch now, with recent layoffs at …